These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4894326)

  • 1. Inhibition of tumor growth by polyinosinic-polycytidylic acid.
    Levy HB; Law LW; Rabson AS
    Proc Natl Acad Sci U S A; 1969 Feb; 62(2):357-61. PubMed ID: 4894326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to tumour biology in the light of prevention, cure and etiology.
    Bose S; Chowdhury JR
    Indian J Cancer; 1972 Jun; 9(2):138-41. PubMed ID: 4635904
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of polyinosinic:polycytidylic acid on tumor metabolism.
    Levy HB; Riley F
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):141-5. PubMed ID: 4920170
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of synthetic double-stranded ribonucleic acid, poly I:C, on Friend leukemia in mice.
    Larson VM; Clark WR; Dagle GE; Hilleman MR
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):602-7. PubMed ID: 5355112
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of synthetic interferon-inducers on malignant tumors and viral oncogenesis].
    Vopr Virusol; 1970; 15(2):247-9. PubMed ID: 4919240
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of leukemic (L-1210) mice with double-stranded polyribonucleotides.
    Zeleznick LD; Bhuyan BK
    Proc Soc Exp Biol Med; 1969 Jan; 130(1):126-8. PubMed ID: 5762487
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
    Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
    Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polyinosinic-polycytidylic acid on induction of primary or transplanted tumors by chemical carcinogen or irradiation.
    Ball JK; McCarter JA
    J Natl Cancer Inst; 1971 May; 46(5):1009-14. PubMed ID: 5157840
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Cancer Chemother Rep; 1971 Jun; 55(3):229-31. PubMed ID: 5115844
    [No Abstract]   [Full Text] [Related]  

  • 12. [Asparaginase, leukemia and cancer].
    Levy D; Boiron M
    Bull Cancer; 1969; 56(4):365-74. PubMed ID: 4928248
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity and antitumor activity of gallium nitrate and periodically related metal salts.
    Hart MM; Smith CF; Yancey ST; Adamson RH
    J Natl Cancer Inst; 1971 Nov; 47(5):1121-7. PubMed ID: 4330799
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems.
    Johnson RK; Houchens DP; Gaston MR; Goldin A
    Cancer Chemother Rep; 1975; 59(4):697-705. PubMed ID: 1175164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
    Tarnowski GS; Schmid FA; Hutchison DJ; Stock CC
    Cancer Chemother Rep; 1973 Feb; 57(1):21-7. PubMed ID: 4704098
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
    Johnson RK; Inouye T; Goldin A; Stark GR
    Cancer Res; 1976 Aug; 36(8):2720-5. PubMed ID: 1064466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liposome encapsulation as a possibility for the improvement of tumor chemotherapy].
    Fichtner I; Reszka R; Elbe B; Arndt D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):658-63. PubMed ID: 6172330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
    Maral R; Bourat G; Ducrot R; Fournel J; Ganter P; Julou L; Koenig F; Myon J; Pascal S; Pasquet J; Populaire P; de Ratuld Y; Werner GH
    Pathol Biol; 1967 Oct; 15(19):903-8. PubMed ID: 4296784
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
    Mantovani A; Polentarutti N; Luini W; Peri G; Spreafico F
    J Natl Cancer Inst; 1979 Jul; 63(1):61-6. PubMed ID: 286835
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.